Literature DB >> 21150177

Imaging of renal cell carcinoma: state of the art and recent advances.

Emilio Sacco1, Francesco Pinto, Angelo Totaro, Alessandro D'Addessi, Marco Racioppi, Gaetano Gulino, Andrea Volpe, Francesco Marangi, Daniele D'Agostino, Pierfrancesco Bassi.   

Abstract

BACKGROUND AND AIM: Renal cell carcinoma (RCC) is the 13th most common cancer worldwide and accounts for 4% of all adult malignancies. Herein the state of the art and recent advances in cross-sectional radiological imaging applied to RCC are reviewed, including ultrasonography, computed tomography, magnetic resonance imaging, and positron emission tomography.
METHODS: Literature search of peer-reviewed papers published by October 2010.
RESULTS: In front of more conventional and widespread imaging tools, such as ultrasonography and computed tomography, an array of newer and attractive radiological modalities are under investigation and show promise to improve our ability to noninvasively detect renal tumors and its recurrences, accurately assess the extent of the disease, and reliably evaluate treatment response, particularly in the era of antiangiogenetic therapy.
CONCLUSIONS: Recent major advances in radiological imaging techniques have considerably improved our ability to diagnose, stage and follow-up RCC. Further studies are needed to evaluate the potential of most recent and still investigational imaging tools.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21150177     DOI: 10.1159/000322724

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  9 in total

Review 1.  Advances in medical imaging for the diagnosis and management of common genitourinary cancers.

Authors:  Mohammad H Bagheri; Mark A Ahlman; Liza Lindenberg; Baris Turkbey; Jeffrey Lin; Ali Cahid Civelek; Ashkan A Malayeri; Piyush K Agarwal; Peter L Choyke; Les R Folio; Andrea B Apolo
Journal:  Urol Oncol       Date:  2017-05-12       Impact factor: 3.498

2.  Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.

Authors:  Ivan Zokalj; Miljenko Marotti; Branko Kolarić
Journal:  Int Urol Nephrol       Date:  2014-01-01       Impact factor: 2.370

Review 3.  Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers.

Authors:  John C Chappell; Laura Beth Payne; W Kimryn Rathmell
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

Review 4.  [Modern tomography imaging techniques in urological diseases].

Authors:  Gita M Schoenberg; Viktoria Schuetz; Joanne N Nyarangi-Dix; Steffen J Diehl; Rafael Heiss; Boris Adamietz
Journal:  Urologe A       Date:  2022-03-09       Impact factor: 0.639

5.  Detecting functional changes with [(18)F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy.

Authors:  David W Chapman; Hans-Sonke Jans; Ivy Ma; John R Mercer; Leonard I Wiebe; Melinda Wuest; Ronald B Moore
Journal:  EJNMMI Res       Date:  2014-09-10       Impact factor: 3.138

6.  Renal imaging in 199 Dutch patients with Birt-Hogg-Dubé syndrome: Screening compliance and outcome.

Authors:  Paul C Johannesma; Irma van de Beek; Tijmen J W T van der Wel; Rinze Reinhard; Lawrence Rozendaal; Theo M Starink; Jan Hein T M van Waesberghe; Simon Horenblas; Hans J J P Gille; Marianne A Jonker; Hanne E J Meijers-Heijboer; Pieter E Postmus; Arjan C Houweling; Jeroen R A van Moorselaar
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

Review 7.  Role of positron emission tomography/computed tomography in the evaluation of renal cell carcinoma.

Authors:  Rahul Jena; Tushar Aditya Narain; Uday Pratap Singh; Aneesh Srivastava
Journal:  Indian J Urol       Date:  2021-04-01

Review 8.  Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.

Authors:  Hsin-Yi Wang; Hueisch-Jy Ding; Jin-Hua Chen; Chih-Hao Chao; Yu-Yu Lu; Wan-Yu Lin; Chia-Hung Kao
Journal:  Cancer Imaging       Date:  2012-10-26       Impact factor: 3.909

9.  Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy.

Authors:  Nina Zeh; Peter J Wild; Peter K Bode; Glen Kristiansen; Holger Moch; Tullio Sulser; Thomas Hermanns
Journal:  BMC Urol       Date:  2013-02-12       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.